Use of neoadjuvant paclitaxel in breast angiosarcoma—Impact on surgical resection and response rates
Luke V. Selby,
Emma Clark,
James L. Chen
et al.
Abstract:ObjectiveBreast angiosarcoma is a tumor that can arise as a primary breast tumor or in association with prior radiation therapy. Angiosarcomas are uniquely sensitive to paclitaxel. This study evaluated the impact neoadjuvant paclitaxel (NAC) therapy has on surgical outcomes, tumor recurrence, and survival in breast angiosarcomas.MethodsPatients with angiosarcoma of the breast, either primary or radiation‐associated, were identified from a prospective institutional database. Patients receiving NAC were compared… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.